Prognostic significance of peripheral microvascular endothelial dysfunction in heart failure with reduced left ventricular ejection fraction

Circulation Journal

Volumn 79, Issue 12, 2015, Pages 2623-2631

  Fujisue, Koichiro ^a   Sugiyama, Seigo ^a   Matsuzawa, Yasushi ^c   Akiyama, Eiichi ^c   Sugamura, Koichi ^a   Matsubara, Junichi ^a   Kurokawa, Hirofumi ^a   Maeda, Hirofumi ^a   Hirata, Yoshihiro ^a   Kusaka, Hiroaki ^a   Yamamoto, Eiichiro ^a   Iwashita, Satomi ^a   Sumida, Hitoshi ^a   Sakamoto, Kenji ^a   Tsujita, Kenichi ^a   Kaikita, Koichi ^a   Hokimoto, Seiji ^a   Matsui, Kunihiko ^b   Ogawa, Hisao ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b KUMAMOTO UNIVERSITY HOSPITAL   (Japan)

^c YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

Author keywords

Endothelial function; Heart failure; Prognosis

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; SODIUM;

AGED; ARTICLE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; ENDOTHELIAL DYSFUNCTION; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART FAILURE; HEART FAILURE WITH REDUCED EJECTION FRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HIGH RISK PATIENT; HUMAN; INTERMEDIATE RISK PATIENT; LOW RISK PATIENT; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERIPHERAL ARTERIAL TONOMETRY; PERIPHERAL MICROVASCULAR ENDOTHELIAL DYSFUNCTION; PROGNOSIS; PROSPECTIVE STUDY; REACTIVE HYPEREMIA PERIPHERAL ARTERIAL TONOMETRY INDEX; RISK ASSESSMENT; SCORING SYSTEM; SODIUM BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE; TRANSTHORACIC ECHOCARDIOGRAPHY; CLINICAL TRIAL; ENDOTHELIUM; HEART STROKE VOLUME; METABOLISM; MICROVASCULATURE; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY;

AGED; ENDOTHELIUM; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; MALE; MICROVESSELS; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; STROKE VOLUME;

EID: 84978971989     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-15-0671     Document Type: Article

References (40)

1. Sakata Y, Shimokawa H. Epidemiology of heart failure in Asia. Circ J 2013; 77: 2209 - 2217.
2. McMurray JJ, Petrie MC, Murdoch DR, Davie AP. Clinical epidemiology of heart failure: Public and private health burden. Eur Heart J 1998; 19(Suppl P): P9 - P16.
3. Braunwald E. Biomarkers in heart failure. N Engl J Med 2008; 358: 2148 - 2159.
4. Tsutamoto T, Wada A, Maeda K, Hisanaga T, Maeda Y, Fukai D, et al. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: Prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation 1997; 96: 509 - 516.
5. Pocock SJ, Ariti CA, McMurray JJ, Maggioni A, Kober L, Squire IB, et al. Predicting survival in heart failure: A risk score based on 39 372 patients from 30 studies. Eur Heart J 2013; 34: 1404 - 1413.
6. Groenveld HF, Januzzi JL, Damman K, van Wijngaarden J, Hillege HL, van Veldhuisen DJ, et al. Anemia and mortality in heart failure patients a systematic review and meta-analysis. J Am Coll Cardiol 2008; 52: 818 - 827.
7. From AM, Leibson CL, Bursi F, Redfield MM, Weston SA, Jacobsen SJ, et al. Diabetes in heart failure: Prevalence and impact on outcome in the population. Am J Med 2006; 119: 591 - 599.
8. Scrutinio D, Mastropasqua F, Guida P, Ammirati E, Ricci V, Raimondo R, et al. Renal dysfunction and accuracy of N-terminal pro-B-type natriuretic peptide in predicting mortality for hospitalized patients with heart failure. Circ J 2014; 78: 2439 - 2446.
9. Marti CN, Gheorghiade M, Kalogeropoulos AP, Georgiopoulou VV, Quyyumi AA, Butler J. Endothelial dysfunction, arterial stiffness, and heart failure. J Am Coll Cardiol 2012; 60: 1455 - 1469.
10. Deanfield JE, Halcox JP, Rabelink TJ. Endothelial function and dysfunction: Testing and clinical relevance. Circulation 2007; 115: 1285 - 1295.
11. Flammer AJ, Anderson T, Celermajer DS, Creager MA, Deanfield J, Ganz P, et al. The assessment of endothelial function: From research into clinical practice. Circulation 2012; 126: 753 - 767.
12. Matsuzawa Y, Guddeti RR, Kwon TG, Lerman LO, Lerman A. Secondary prevention strategy of cardiovascular disease using endothelial function testing. Circ J 2015; 79: 685 - 694.
13. Fischer D, Rossa S, Landmesser U, Spiekermann S, Engberding N, Hornig B, et al. Endothelial dysfunction in patients with chronic heart failure is independently associated with increased incidence of hospitalization, cardiac transplantation, or death. Eur Heart J 2005; 26: 65 - 69.
14. Meyer B, Mortl D, Strecker K, Hulsmann M, Kulemann V, Neunteufl T, et al. Flow-mediated vasodilation predicts outcome in patients with chronic heart failure: Comparison with B-type natriuretic peptide. J Am Coll Cardiol 2005; 46: 1011 - 1018.
15. Katz SD, Hryniewicz K, Hriljac I, Balidemaj K, Dimayuga C, Hudaihed A, et al. Vascular endothelial dysfunction and mortality risk in patients with chronic heart failure. Circulation 2005; 111: 310 - 314.
16. Kuvin JT, Karas RH. Clinical utility of endothelial function testing: Ready for prime time? Circulation 2003; 107: 3243 - 3247.
17. Bonetti PO, Barsness GW, Keelan PC, Schnell TI, Pumper GM, Kuvin JT, et al. Enhanced external counterpulsation improves endothelial function in patients with symptomatic coronary artery disease. J Am Coll Cardiol 2003; 41: 1761 - 1768.
18. Akiyama E, Sugiyama S, Matsuzawa Y, Konishi M, Suzuki H, Nozaki T, et al. Incremental prognostic significance of peripheral endothelial dysfunction in patients with heart failure with normal left ventricular ejection fraction. J Am Coll Cardiol 2012; 60: 1778 - 1786.
19. Hamburg NM, Palmisano J, Larson MG, Sullivan LM, Lehman BT, Vasan RS, et al. Relation of brachial and digital measures of vascular function in the community: The Framingham heart study. Hypertension 2011; 57: 390 - 396.
20. McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: The Framingham study. N Engl J Med 1971; 285: 1441 - 1446.
21. Levy WC, Mozaffarian D, Linker DT, Sutradhar SC, Anker SD, Cropp AB, et al. The Seattle Heart Failure Model: Prediction of survival in heart failure. Circulation 2006; 113: 1424 - 1433.
22. D'Agostino RB Jr. Propensity scores in cardiovascular research. Circulation 2007; 115: 2340 - 2343.
23. Vansteelandt S, Daniel RM. On regression adjustment for the propensity score. Stat Med 2014; 33: 4053 - 4072.
24. Miller TD, Askew JW. Net reclassification improvement and integrated discrimination improvement: New standards for evaluating the incremental value of stress imaging for risk assessment. Circ Cardiovasc Imaging 2013; 6: 496 - 498.
25. Hillege HL, Girbes AR, de Kam PJ, Boomsma F, de Zeeuw D, Charlesworth A, et al. Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation 2000; 102: 203 - 210.
26. Treasure CB, Vita JA, Cox DA, Fish RD, Gordon JB, Mudge GH, et al. Endothelium-dependent dilation of the coronary microvasculature is impaired in dilated cardiomyopathy. Circulation 1990; 81: 772 - 779.
27. Kubo SH, Rector TS, Bank AJ, Williams RE, Heifetz SM. Endothelium- dependent vasodilation is attenuated in patients with heart failure. Circulation 1991; 84: 1589 - 1596.
28. Hamburg NM, Keyes MJ, Larson MG, Vasan RS, Schnabel R, Pryde MM, et al. Cross-sectional relations of digital vascular function to cardiovascular risk factors in the Framingham Heart Study. Circulation 2008; 117: 2467 - 2474.
29. Ras RT, Streppel MT, Draijer R, Zock PL. Flow-mediated dilation and cardiovascular risk prediction: A systematic review with metaanalysis. Int J Cardiol 2013; 168: 344 - 351.
30. Xu Y, Arora RC, Hiebert BM, Lerner B, Szwajcer A, McDonald K, et al. Non-invasive endothelial function testing and the risk of adverse outcomes: A systematic review and meta-analysis. Eur Heart J Cardiovasc Imaging 2014; 15: 736 - 746.
31. Lind L, Berglund L, Larsson A, Sundstrom J. Endothelial function in resistance and conduit arteries and 5-year risk of cardiovascular disease. Circulation 2011; 123: 1545 - 1551.
32. Borel JC, Roux-Lombard P, Tamisier R, Arnaud C, Monneret D, Arnol N, et al. Endothelial dysfunction and specific inflammation in obesity hypoventilation syndrome. PLoS One 2009; 4: e6733, doi:10.1371/journal.pone.0006733.
33. Osika W, Montgomery SM, Dangardt F, Wahrborg P, Gan LM, Tideman E, et al. Anger, depression and anxiety associated with endothelial function in childhood and adolescence. Arch Dis Child 2011; 96: 38 - 43.
34. Nozaki T, Sugiyama S, Sugamura K, Ohba K, Matsuzawa Y, Konishi M, et al. Prognostic value of endothelial microparticles in patients with heart failure. Eur J Heart Fail 2010; 12: 1223 - 1228.
35. Zelis R, Sinoway LI, Musch TI, Davis D, Just H. Regional blood flow in congestive heart failure: Concept of compensatory mechanisms with short and long time constants. Am J Cardiol 1988; 62: 2E - 8E.
36. Borlaug BA. Mechanisms of exercise intolerance in heart failure with preserved ejection fraction. Circ J 2014; 78: 20 - 32.
37. Hambrecht R, Hilbrich L, Erbs S, Gielen S, Fiehn E, Schoene N, et al. Correction of endothelial dysfunction in chronic heart failure: Additional effects of exercise training and oral L-arginine supplementation. J Am Coll Cardiol 2000; 35: 706 - 713.
38. Hambrecht R, Fiehn E, Weigl C, Gielen S, Hamann C, Kaiser R, et al. Regular physical exercise corrects endothelial dysfunction and improves exercise capacity in patients with chronic heart failure. Circulation 1998; 98: 2709 - 2715.
39. Mulder P, Elfertak L, Richard V, Compagnon P, Devaux B, Henry JP, et al. Peripheral artery structure and endothelial function in heart failure: Effect of ACE inhibition. Am J Physiol 1996; 271: H469 - H477.
40. Enomoto K, Yamabe H, Toyama K, Matsuzawa Y, Yamamuro M, Uemura T, et al. Improvement effect on endothelial function in patients with congestive heart failure treated with cardiac resynchronization therapy. J Cardiol 2011; 58: 69 - 73.